English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/4302
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice

AuthorsGonzález-Navarro, Herminia ; Vila-Caballer, Marian; Pastor, María Francisca; Vinué, Ángela ; White, Morris F.; Burks, Deborah J.; Andrés, Vicente
KeywordsAtherosclerosis
Diabetes
Hypercholesterolemia
Insulin receptor substrate 2
Insulin
Insulin resistance
Genetically-modified mice
Issue DateJan-2007
PublisherFrontiers in Bioscience Publications
CitationFrontiers in Bioscience 12, 2291-2298
AbstractAtherosclerosis is increased in type 2 diabetic patients but the precise mechanisms underlying this predisposition remain vague. Mice deficient for insulin receptor substrate 2 (IRS2) develop type 2-like diabetes and thus, provide a model to explore the molecular connection between deranged carbohydrate metabolism and atherosclerosis. To explore the relationship between defective insulin signalling and atherosclerosis, we have examined the development of atherosclerosis in the following groups of fat-fed mice: wild-type, diabetic Irs2-null (Irs2-/-), atherosclerosis-prone apolipoprotein E-null (apoE-/-), and doubly-deficient apoE-/-Irs2-/-. Surprisingly, glucose levels of apoE-/-Irs2-/- mice were comparable to those seen in wild-type and apoE-/- and significantly lower than in Irs2-/- mice. Irs2-/- and apoE-/-Irs2-/- were hyperinsulinemic compared to wild-type and apoE-/- mice. Atherosclerotic lesions were barely detectable in wild-type and Irs2-/- mice, which displayed moderate hypercholesterolemia (~280 mg/dL). Notably, atherosclerosis was significantly enhanced in apoE-/-Irs2-/- compared with apoE-/- mice, although both models displayed similar levels of severe hypercholesterolemia (>600 mg/dL). Circulating insulin levels predicted atherosclerotic lesion burden in apoE-/-Irs2-/- mice. Our results suggest that hyperinsulinemia as a result of Irs2 genetic ablation contributes to increased atherosclerosis when combined with severe hypercholesterolemia (apoE-/-Irs2-/- mice) in the absence of hyperglycaemia, thus implicating IRS2 as an important modulator of murine hypercholesterolemia-dependent atherosclerosis. Future studies are necessary to determine whether IRS2 dysfunction may promote atherosclerosis in normoglycemic, prediabetic patients with clinical manifestations of hyperinsulinemia and insulin resistance.
DescriptionThis is an, un-copyedited, author manuscript that has been accepted for publication in the Frontiers in Bioscience
URIhttp://hdl.handle.net/10261/4302
DOI10.2741/2231
Appears in Collections:(IBV) Artículos
Files in This Item:
File Description SizeFormat 
Front Biosci 012-02291.pdf353,42 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.